
Opinion|Videos|March 18, 2024
Closing Thoughts on the Current Ovarian Cancer Treatment Landscape
Key Takeaways
Ronald D. Alvarez, MD, MBA, provides closing commentary on the current ovarian cancer treatment landscape and the promising outlook over the next 20 years.
Advertisement
Episodes in this series

Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Flow Cytometry Tracks CAR T-Cell Therapy Persistence in Aggressive LBCL
2
Newly Identified RTEL1 Variant Could Broaden Genetic Landscape of Familial PF
3
2025 Hypertension Guideline Updates Presented at AHA Scientific Sessions
4
Inside the VA’s Hub-and-Spoke Model for Multiple Sclerosis Care: Rebecca Spain, MD
5
















































